FDA Approves First Non-Opioid Painkiller in Over Two Decades
- The U.S. Food and Drug Administration approved Vertex Pharmaceuticals' Journavx, the first non-opioid painkiller in over two decades, for short-term pain relief following surgery or injuries.
- Two studies indicated that Journavx provided more relief than a placebo but did not outperform a common opioid-acetaminophen combination pill.
- Vertex's drug works by blocking proteins that trigger pain signals rather than binding to brain receptors like opioids.
- Experts express cautious optimism about Journavx's potential, noting its unique mechanism of action and reduced risk of addiction compared to opioids.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left19Leaning Right8Center62Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
L 21%
C 70%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
